Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra

This study has been completed.
Sponsor:
Collaborators:
Magee-Womens Hospital
Organon
Information provided by:
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00269620
First received: September 12, 2005
Last updated: October 20, 2008
Last verified: October 2008